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Sumnlal'y 
The CD4 protein is expressed on a subset of human T  lymphocytes that recognize antigen in 
the context of major histocompatibility complex (MHC) class II molecules.  Using Chinese hamster 
ovary (CHO) cells expressing human CD4, we have previously demonstrated that the CD4 protein 
can mediate cell adhesion by direct interaction with MHC class II molecules. In T lymphocytes, 
CD4 can also function as a signaling molecule, presumably through its intracellular association 
with p56 ~k,  a member of the src family of protein tyrosine kinases.  In the present report,  we 
show that p56  ~k can affect cell adhesion mediated by CD4 and MHC class II molecules. The 
expression of wild-type p56 ~k in CHO-CD4 cells augments the binding of MHC class II + B 
cells,  whereas the expression of a mutant  p56 ~  protein with  elevated tyrosine kinase activity 
results in decreased binding of MHC class II + B cells. Using site-specific  mutants of p56 ~k, we 
demonstrate  that  the both the enzymatic activity of p56 ~k and its association with  CD4  are 
required for this effect on CD4/MHC  class II adhesion.  Further,  the binding  of MHC class 
II §  B  cells  induces  CD4  at  the  cell surface  to become organized  into  structures  resembling 
adherens-type junctions.  Both wild-type and mutant  forms of p56 ~k influence CD4-mediated 
adhesion by regulating  the formation  of these structures.  The wild-type/ck protein enhances 
CD4/MHC class II adhesion by augmenting the formation of CD4-associated adherensjunctions 
whereas the elevated tyrosine kinase activity of the mutant p56 ~k decreases  CD4-mediated cell 
adhesion by preventing  the formation  of these structures. 
T 
heir cell-cell adhesion between T lymphocytes and their 
targets  is an important  prerequisite for efficient T  cell 
stimulation.  Initial  interactions  are  mediated,  in  part,  by 
members  of the  integrin  family,  including  LFA-1,  whose 
avidity for its  counter-receptor  on  target  cells  can be up- 
regulated through  occupancy and signaling  through  the T 
cell receptor (reviewed in references 1, 2). The antigen-specific 
or/3 TCR recognizes foreign peptides displayed within the 
polymorphic antigen-binding  cleft of MHC molecules (3). 
Both CD4, on helper T cells, and CD8, on cytotoxic T cells, 
also play an important role in efficient T cell activation. The 
role of CD4 and CD8 as co-receptors important for antigen 
recognition and signaling  has now become established (4), 
however, their importance as adhesion molecules remains con- 
troversial.  We have previously demonstrated  an interaction 
between human CD4 and MHC class II molecules that can 
mediate cell adhesion  even in the absence of the TCR. (5, 
6). Similar studies have demonstrated an interaction between 
CD8  and MHC class  I molecules  (7). 
We have recently reported the characterization  of CD4/class 
II adhesion using Chinese hamster ovary (CHO) t cells that 
1 Abbreviation used in this paper: CHO, Chinese hamster ovary. 
express the human CD4 protein on the cell surface (CHO- 
CD4 cells) (6). Cell adhesion mediated by CD4 and MHC 
class II molecules is energy dependent  and an intact  cyto- 
skeleton is required for the establishment  and maintenance 
of stable cell conjugates. Analysis of the time course of cell 
binding revealed that the adhesion of radiolabeled MHC class 
II + Raji B cells  was only detected after 2 h  of incubation 
at 37~  yet cell conjugates remained  stably associated for 
at least 6-8 h  thereafter.  We therefore questioned whether 
the observed time course for CD4/class II adhesion was phys- 
iologically relevant and sought to determine whether other 
T  cell molecules, not  present  in CHO cells,  might  be in- 
volved in regulating  adhesion/de-adhesion  events. 
p5C  k, a lymphoid-specific tyrosine kinase, is associated in- 
tracellularly with CD4 (for review see references 8, 9), sug- 
gesting that  the lck protein might  somehow play a regula- 
tory role in adhesion through CD4. To test this hypothesis, 
we expressed either the wild-type (p56 ~k Y505) or a mutant 
form (p56 tck F505) of the Ick protein in CHO-CD4 cells. In 
resting T lymphocytes, the p56  ~k protein is phosphorylated 
at its carboxy-terminal tyrosine residue (10-12) and replace- 
ment of Y505 by phenylalanine (F505) results in an activated 
form of the protein that has been shown to cause oncogenic 
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T  cell activation, it is thought that the CD45 phosphatase 
acts to dephosphorylate Y505, thereby activating the p56 ~k 
protein (14, 15). Less well understood is the concomitant phos- 
phorylation at Y394, that appears to be required for the ki- 
nase activity of the protein (16-18).  In vivo phosphorylation 
at this site can be measured in cells expressing the F505 form 
of the kinase, and to a lesser extent, upon antibody-mediated 
cross-linking of surface CD4 on cells expressing the wild- 
type kinase (12, 18, 19). Antibody-mediated cross-linking of 
cell surface CD4 also results in the increased kinase activity 
of p56 ~k as measured by in vitro kinase assay (11). Mutation 
of tyrosine to phenylalanine at position 394 prevents the ac- 
tivation of p56 ~k by CD4 cross-linking, implying that phos- 
phorylation at this site provides a crucial positive regulatory 
signal. 
In  this  report,  we  demonstrate  that  the  expression  of 
p56 t'k can dramatically alter cell adhesion mediated by CD4 
and MHC class II molecules. Both the magnitude and time 
course of B cell adhesion to CHO-CD4 cells are affected by 
the presence of the p56  ~k protein and mutations in the Ick 
protein which affect its enzymatic activity alter its ability 
to enhance CD4/class II interactions. In the presence of the 
wild-type protein, cell surface CD4 protein becomes clustered 
at  regions  of cell-cell  contact  into  structures  resembling 
adherens-typejunctions (20-22). Further, a large proportion 
of cell surface CD4 molecules are found to be associated with 
the actin cytoskeleton in the presence  of the wild type pro- 
tein. By contrast, adherens type  junctions are not seen in the 
presence  of the constitutively active F505  mutant of p56 ~k 
nor is the enhanced association of cell surface CD4 with the 
cytoskeleton. These observations suggest a mechanism by 
which the kk protein tethers CD4 molecules to the actin 
cytoskeleton thereby facilitating or stabilizing the clustering 
of CD4 molecules on the cell surface resulting in enhanced 
cell adhesion. 
Materials and Methods 
Cell Cuhure and Antibodies.  B lymphoblastoid cell lines and hy- 
bridomas were cultured in RPMI (R.PMI 1640; GIBCO BILL, 
Gaithersburg, MD) supplemented with 10% FCS, 15 mM Hepes, 
2 mM glutamine, penicillin, and streptomycin. CHO-DUKX II 
(CD4-)  and  CHO-CD4  ceUs were maintained  in  MEM-ct 
(GIBCO BILL)  as described (6, 23). Hybridomas  secreting  the mAbs 
TS1/18 (anti-LFAl~; CD18), TS1/22 (anti-LFAlot; CDlla; refer- 
ence 24), OKT4 (mouse anti-human CD4), and GK1.5 (rat anti- 
L3T4) were obtained from the American Type Culture Collection 
(Kockville, MA) and used as culture supernatants or ascites fluid. 
Transfection of p56 ~k.  CHO-DUKX  II  or  CHO-CD4  cells 
were co-transfected with 20/~g of the pNUT recombinant expres- 
sion vector containing the murine wild-type (Y505) or mutant 
(F505) p56  ~  cDNAs  (generously provided by  K.  Perlmutter, 
University of Washington, Seattle, WA) and 2.0/~g of the pCDneo 
plasmid using the BES-(N,N-bis-[2-hydroxyethyl]-2-aminoethane- 
sulfonic acid; Calbiochem-Novabiochem Corp., La Jolla, CA) cal- 
cium phosphate transfection technique (6, 25). After transfection, 
the cells were selected  in media containing 150/zg/ml G418 (GIBCO 
BRL) and survivors were cloned by limiting dilution. 
Northern Blot Analysis.  Total  cellular KNA was isolated  by acid 
guanidium-phenol-chloroform  extraction (26). 15/zg of RNA was 
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size fractionated by formaldehyde-agarose  gel electrophoresis (27) 
and blotted onto Hybond-N (Amersham  Corp., Arlington Heights, 
IL) nylon membrane. Hybridization and washing was performed 
as described (28). The probe was the Sinai fragment (625-1,382 
bp) of the p56 ~  cDNA  that was radiolabeled with [32p]dCTP 
using the random primed DNA labeling kit (United States Bio- 
chemical Corp., Cleveland, OH). 
Immunoblotting.  5 x  106 cells were washed with PBS and lysed 
in a solution containing 50 mM Tris-HC1, pH 8.0, 1% NP-40, 
2 mM EDTA, 100/zM Na3VO4, 18 mg/ml PMSF, and 20 #g/ml 
leupeptin. Human CD4 was immunoprecipitated  from CHO-CD4 
cells using the OKT4 mAb and murine CD4 was immunoprecipi- 
tated from LSTRA cells using the GK1.5 mAb. SDS-PAGE and 
immunoblot  analysis with anti-p56 ~  rabbit polyclonal antisera 
(kindly provided by Dr. Roger Perlmutter, University of Wash- 
ington) was also performed as described (29). Immunoreactive  pro- 
teins were visualized using alkaline phosphatase-conjugated goat 
anti-rabbit IgG (GIBCO BRL) or lz~I-labeled  protein A-Sepharose, 
as indicated. 
Cell Adhesion Assay.  The binding of radiolabeled Raji B cells 
to adherent CHO (_+ p56  ~k) cells was performed as previously  de- 
scribed (6). All of the results presented in the text are averages of 
duplicate samples. For optimal binding, 0.25 ml of radiolabeled 
Raji B cells were added to each confluent CHO-containing  well 
yielding a final  volume of 0.5 ml containing 1 x  106 B cells/well 
and incubated at 37~  in 5% CO2 for 1-4 h. Unbound labeled 
B cells were removed by repeated washes in PBS (+1 mM Ca  2+, 
Mg  z+) and the remaining bound cells were disrupted by hypotonic 
lysis. Radioactivity was measured in a ~ counter and the number 
of cells bound in each well was quantified by the following al- 
gorithm:  cells bound  =  number of added cells  x  experimental 
value (cpm bound)/(total  cpm). 
Cytoskeletal Association Assay.  The association between CD4 
and the cytoskeleton was assessed as previously described (30). 
Briefly, CHO-CD4 ceils, resuspended in trypsin-EDTA solution 
(GIBCO BRL), were stained with FITC-conjugated OKT4 mAbs 
(Ortho Diagnostic Systems Inc., Westwood, MA) for 1 h at 4~ 
Molecules not associated with the cytoskeleton were solubilized 
by treatment with detergent (1.0% NP-40) for 20 min at room 
temperature. After two washes with PBS, samples were analyzed 
by flow cytometry (FACS| 
AdherensJunction Assay.  CHO-CD4 cells, grown to confluence 
in eight-well chamber slides (Nunc Roskilde, Denmark), were in- 
cubated with 1 x  105 Raji B cells for 4 h at 37~  washed at 4~ 
to remove bound Raft B cells, and fixed with 3.7%  formalde- 
hyde/PBS solution for 30 rain at room temperature. After three 
washes with 50 mM NH4C1/PBS, the samples were permeabilized 
with 0.05%  NP-40/PBS for 20 min at room temperature and 
washed with PBS. The samples were then incubated for 30 min 
each at room temperature with relevant  primary and secondary  an- 
tibodies. Samples were mounted  with  FluorSave (Calbiochem 
Novabiochem Corp., La Jolla, CA) to minimize photobleaching 
and observed by indirect immunofluorescence  microscopy (x 630, 
Zeiss). Adherens  junction formation was scored in coded samples 
by assessing the fraction of CHO-CD4 ceUs displaying  aggregated 
molecule(s). At least 100 CHO cells in at least 10 different fields 
of view were counted per sample and the data presented is repre- 
sentative of at least three separate experiments. 
Site-directed Oligonucleotide Mutagenesis.  Point mutants of the 
p56  ~k molecule were constructed by site-directed mutagenesis ac- 
cording to the method of  Kunkel (31). The following mismatched 
oligonucleotides (mutation underlined): CA20 (cysteine  to alanine 
at  residue 20): S'(ACATTGACGTG  _GCTGAA)3'; YF394 (tyro- 
sine to phenylalanine at residue 394): S'(GGACAATGAGTTCA 
Adhesion CGG)  3',  and KA273  (lysine to alanine at  residue 273): S'(TGG- 
CGGTGGCGAGTCTGA) y, were annealed to M13-p56  k~ single- 
stranded uracil-containing template DNA and second strand syn- 
thesis was carried out as recommended  by the manufacturer (Bio-Rad 
Laboratories, Cambridge, MA). Mutants were screened  by dideoxy- 
sequence analysis using the Sequenase enzyme (Version 2; United 
States Biochemical Corp.) and double-stranded mutant DNA was 
ligated into the pNUT expression vector (13) for amplification in 
Escherichia  coli (DH-5o  0 and subsequent transfection into CHO cells. 
Results 
Expression  of p56 ~k in  CHO-CD4  Cells.  CHO-DUKX 
(CD4  negative)  and  CHO-CD4  (0.80  Izm  methotrexate 
[MTX]) cells were co-transfected with plasmids encoding re- 
sistance  to neomycin and either wild-type p56 ~k (Y505) or 
a previously described mutant  p56  ~k cDNA that  encodes a 
phenylalanine in place of the tyrosine at residue 505 (p561ok 
F505) (13). Subclones of transfected cells were isolated by lim- 
iting  dilution.  The  presence  of p56  ~  was  confirmed  by 
Northern  blot  analysis  and  immunoblotting  of CD4  im- 
munoprecipitates  with p56  ~k antisera  (Fig.  1).  In addition, 
both wild-type and mutant  forms of p56 ~  were shown to 
promote in vivo tyrosine phosphorylation ofceUular substrates 
in p56tck-transfected  CHO-CD4 cells as assessed by immu- 
noprecipitation and Western blotting with phosphotyrosine- 
specific  antibodies  (data not  shown). 
p56  ~k Regulates CD4/MHC  Class II Adhesion.  Cell adhe- 
sion assays were performed using transfected CHO-CD4 cells 
(+_p56  ~) and MHC class II-positive Raji B lymphoblastoid 
cells.  After incubation of the CHO-CD4 monolayers with 
radiolabeled Raji B cells for 1-4 h  at 37~  the plates were 
washed vigorously to remove unbound cells. The remaining 
bound cells  were lysed and radioactivity was measured.  In 
all cases, cells expressing wild-type p56  ~k (CHO-CD4-Y505 
cells)  displayed enhanced binding of Raji cells as compared 
to CHO-CD4 cells lacking p56  ~k (Fig.  2 A).  Clones 5 and 
7 are representative and were those used in the experiments 
presented in this report.  Both the magnitude as well as the 
time course of CD4/MHC class II adhesion were profoundly 
Figure  1.  The  expression of 
p56  I,~  in  CHO-CD4  cells. 
Northern blot analysis of KNA 
(top) isolated  from LSTKA, a mu- 
fine thymoma that overexpresses 
p561,~  (lane  1;  reference 60) 
CHO-DUKX II (CD4-negative) 
(lane 2),  CHO-CD4  (lane 3), 
CHO-CD4 cells  transfected  with 
p56  ~  F505 (CHO-CD4-F505, 
clone 2) (lane  4), and CHO-CD4 
cells transfected with wild-type 
p56  ~  Y505 (CHO-CD4-Y505, 
clone 5) (lane 5) cells. The rela- 
tive mobilities of 28S and  18S 
ribosomal KNA  are  indicated 
(arrows) and  ethidium bromide 
staining of total R.NA is  also 
shown  (middle). Immunoblot 
analysis of CD4 immunoprecipi- 
tates using p56  t,~ specific rabbit 
polyclonal antiserum (bottom). 
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Figure 2.  p56/~k regulates  CD4/MHC  class II  adhesion.  (.4)  The 
binding of radiolabeled Raji B cells to confluent monolayers of CHO- 
DUKX II (CD4-negative)  (11) and CHO-CD4 (l~) clones expressing 
the wild-type (Y505) or mutant (F505) forms of p56/'k. Binding was as- 
sessed after 4 h of incubation at 37~  (B) Time course of binding of ra- 
diolabeled Raji B cells to CHO-CD4 (l-q), CHO-CD4-Y505, clone 5 (O), 
and CHO-CD4-F505, clone 2 (A). 
altered (Fig.  2 B). Whereas adhesion of radiolabeled Raft B 
lymphocytes to CHO-CD4  monolayers was only detected 
after 2-4 h  of incubation  (1.5  x  105 radiolabeled B  ceils), 
similar levels of B cell adhesion to CHO-CD4-Y cells were 
readily observed within 1 h after the addition of radiolabeled 
B  cells  and  continued  to increase for 6 h  until  5.3  x  10  s 
B cells were bound. By contrast, the binding of Raji to CHO- 
CD4 cells transfected with the mutant F505 kinase (CHO- 
CD4-F505 clones 2 and 4) was comparable to or less than 
binding to CHO-CD4 cells (Fig. 2, A and B). Direct visual- 
ization of a typical binding assay, using tubulin-specific anti- 
bodies that stained both the CHO and Raji B cells, revealed 
that individual  CHO-CD4-Y505 cells bound multiple B lym- 
phocytes whereas CHO-CD4 and CHO-CD4-F505 clones 
bound single MHC class II + B cells (Fig.  3). All assays were 
performed in media containing  antibodies  directed  against 
LFA-1 (mAb TS1/22) to prevent homotypic aggregation of 
human  B  lymphocytes  (6).  Therefore,  we  interpret  this 
dustering to represent the simultaneous binding of multiple 
Raji B cells to individual CHO-CD4-Y505  cells.  Increased 
binding was dependent  upon the interaction  of CD4 with 
MHC class  II molecules,  inasmuch  as the binding  of Raji Figure  3.  Multiple  MHC dass II * Raft B 
cells bind  CHO-CD4-Y505 calls. The binding 
of Raft B cells to monolayers  of CHO-CD4 
(/eft), CHO-CD4-YS05, clone  5 (middle) and 
CHO-CD4-F505, clone  2 (right) cells  after  4 h 
of incubation at 37~  was visualized  by in- 
direct immunofluorescence  staining  of  both cell 
types with the tubulin-specific  mAb YL1/2 
(BioProducts for Science, Indianapolis,  IN). 
to CHO-DUKX II (CD4-negative) cells transfected with ei- 
ther wild-type or mutant kinase was equivalent to untrans- 
fected controls (Fig.  2 A, CHO-DUKX-Y505  and CHO- 
DUKX-F505). Moreover, the binding of Raji to CHO-CD4- 
Y505  and CHO-CD4-F505  cells was completely inhibited 
by CD4 and MHC class II-specific mAbs (data not shown). 
A trivial explanation for the altered binding of MHC class 
II + B cells to CHO-CD4-Y505  and CHO-CD4-F505 cells 
is that expression of p56  ~k resulted in increased levels of CD4 
at the cell surface.  Indeed, the expression of p56 ~k in non- 
lymphoid cells inhibits CD4 endocytosis by excluding CD4 
from coated pits (32,  33).  However, despite a dramatic in- 
crease in adhesion, CHO-CD4-Y505, clone 5, displayed levels 
of CD4 at the cell surface that were comparable to CHO- 
CD4 cells, as determined by immunostaining and FACS  |  anal- 
ysis (Fig. 4). Further, reduced adhesion of Raft to CHO-CD4- 
F505, clone 2, was observed even though this clone displayed 
more CD4 at the cell surface than CHO-CD4 cells or CHO- 
CD4-Y505,  clone 5 (Fig.  4).  Thus,  the altered binding of 
Raji cells to CHO-CD4-Y505 cells or CHO-CD4-F505 cells 
was not the result of altered surface expression  of CD4 in 
transfected cells. 
Overexpression of  src kinases has been demonstrated to cause 
changes in cell morphology and the expression  of the acti- 
vated form of p56 ~k in NIH 3T3 cells has previously been 
shown to cause morphologic transformation (13). We there- 
fore asked whether CHO-CD4-transfected cells were affected 
by the expression of either form of the lck protein.  There 
were no obvious differences in growth rates, cell size, or shape. 
Cytoskeletal structure, including microtubule and microfda- 
ment organization, was comparable in transfectants (in the 
absence  of  Raji  B  cells)  as  determined  by  indirect  im- 
munofluorescence microscopy of  permeabilized  cells (data not 
shown).  Finally, to  determine whether expression  of any 
member of the src family of tyrosine kinases in CHO-CD4 
cells was sufficient to modify CD4-class II adhesion, we trans- 
fected a plasmid encoding the c-src protein into CHO-CD4 
cells (Fig.  5 A).  Over-expression of c-src, which does  not 
specifically interact with CD4, did not significantly  alter Raji 
binding (P <0.05). 
The Association of CD4 and p56  l~k Is Required for the Regu- 
lation of  MHC Class II Adhesion.  In resting T lymphocytes, 
CD4  is  stably associated  with p56 ~.  This intermolecular 
binding is facilitated  by interactions between two pairs  of 
cysteine residues in the amino terminal domain of p56 ~k and 
in the cytoplasmic domain of CD4. Mutation of any of these 
cysteines completely abrogates the association  of CD4 and 
p56  t+~ (29, 34, 35). To examine whether the association be- 
tween  CD4  and  p56 ~k  is  required  for  the  regulation  of 
CD4/MHC class II binding, an alanine was substituted for 
the cysteine at position 20 in the cDNA(s) encoding both 
the Y505  and F505 forms of p56 ~k. The mutant constructs 
(Y505 c^2~  or F505 cam) were then expressed in CHO-CD4 
cells and control experiments were performed to demonstrate 
that the/ck protein could not be immunoprecipitated in as- 
sociation with CD4 (data not shown). Adhesion assays were 
CHO-CD4 
,h~k,,..~,,= 
CHO-CD4 
Y505 
CHO-CD4 
F505 
........  I  ........  l  ~'"  +  ......  l 
Figure 4.  Cell  surface  expression  of CD4 in CHO-CD4 cells (_+p56~). 
CHO-CD4, CHO-CD4-YS05 (clone  5), and CHO-CD4-F505 (clone  2) 
cells  were  stained  with the OKT4  mAb followed  by FITC-conjugated  goat 
anti-mouse IgG and analyzed  by FACS  | 
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The association of CD4 and p56  t'k is necessary  for enhanced 
MHC class II adhesion. Time course of binding of radiolabeled Raji B 
cells to monohyers  ofCHO-CD4 (~), CHO-CD4-Y505  (O), CHO-CD4- 
Y505  c^2~ (O), and CHO-CD4"~ (11) cells. (/3) Time course of binding 
of radiolabeled Raji B cells  to monolayers  of CHO-CD4 (IS]), CHO-CD4- 
F505 (A), and CHO-CD4-FS05  c^20 (A) cells. 
then performed as described above.  The binding of Raji to 
CHO-CD4  cells  expressing the single mutant  (Y505  c^2~ 
was decreased as compared with CHO-CD4-Y505 cells; dis- 
playing kinetics and magnitude of binding that were similar 
to CHO-CD4 cells (Fig. 5 A). By contrast,  the binding of 
Raji  to  CHO-CD4-F505 c^2~ cells  was  not  significantly 
different from CHO-CD4-F505 cells (Fig.  5 B). These data 
demonstrate that the specific association of wild-type p56 t'k 
with CD4 is necessary for the rapid time course and aug- 
mented binding  of MHC class II-expressing  B  cells. 
The Enzymatic Activity of p56  ~k Is Required  for Enhanced 
CD4/Class II Adhesion.  To address whether the enzymatic 
activity of p56 t'k was important  for its regulation of CD4/ 
MHC class II adhesion,  a lysine to alanine change was en- 
gineered at residue 273 (KA273) which has previously been 
shown to be essential for the phosphotransferase activity of 
the  protein  (36).  CHO-CD4  cells  expressing  the  kinase- 
deficient form of the protein (CHO-CD4-Y505 KA273) bound 
fewer Raji cells as compared with  CHO-CD4-Y505  cells; 
both the time course and magnitude  of adhesion were de- 
creased (Fig.  6 A). To confirm further that the tyrosine ki- 
nase  activity  of wild-type  p56 ~k was  important  for  aug- 
mented CD4/MHC class II adhesion, the binding assay was 
1733  Kinch  et al. 
performed in the presence of genistein; an ATP analogue that 
specifically binds the catalytic subunit of tyrosine kinases (Fig. 
6 B) (37).  The binding  of Raji to genistein-treated  CHO- 
CD4-Y505 cells was equivalent to parental CHO-CD4 cells; 
fewer Raji cells bound genistein-treated  CHO-CD4-Y505 
cells. Genistein had little or no effect in binding assays using 
CHO-CD4 cells or CHO-CD4-F505 cells presumably due 
to the small differences between the number of Raji cells bound 
to these transfectants  at the 4 h  time point when binding 
was measured.  Thus,  both the constitutively active (p56 ~k 
F505)  as  well  as  inactive  forms  of the  wild-type  kinase 
(p561ckY505 K^273  or  genestein-treated  CHO-CD4-Y505 
cells) fail to augment CD4/MHC class II adhesion. Rather, 
this appears to be a unique property of wild-type kk protein. 
To further analyze the functional requirements of the trans- 
fected Ick proteins expressed in CHO-CD4 cells,  the tyro- 
sine at position 394 was changed to phenylalanine (YF394) 
to abrogate the enzymatic activity of Ick. Previous studies 
have demonstrated that the tyrosine kinase activity of p56 lc~ 
is positively regulated by a critical  tyrosine at  residue 394 
and mutation  of this residue prevents the activation of Ick 
(17).  Again,  mutations  which rendered  the protein kinase 
deficient resulted in a loss of phenotype ascribed to the kinase- 
active proteins. CHO-CD4-Y505 YF394 cells bound fewer Raji 
cells  as compared with  CHO-CD4-Y505  cells  (Fig.  6 C), 
whereas the binding  of Raji to CHO-CD4-F505 YF394 cells 
was slightly increased as compared to CHO-CD4-F505 cells 
(Fig.  6 D).  These data are consistent with results obtained 
with KA273 mutants implying that the YF394 mutation is 
functionally equivalent to the KA273 mutation in this assay. 
Moreover, the observed differences in activity between con- 
structs that are wild-type at position 394 and those in which 
the tyrosine has been changed to phenylalanine (YF394) sug- 
gest that p56 l'k can be regulated by phosphorylation  at po- 
sition 394 in CHO cells,  consistent with reports that  this 
site is autophosphorylated in vivo. Finally,  the levels of the 
lck kinase in each of the transfectants  were analysed by Western 
blotting using lck-specific antisera (Fig. 7). All of the trans- 
fectants appeared to express similar levels of wild-type or mu- 
tant forms of the protein suggesting that differences in adhe- 
sion observed with transfectants were not due to variability 
in the levels  of p56 t'~. 
CD4-associated Adherens-type  Junctions.  A reorganization 
of CD4 and cytoskeletal elements within the cell membrane 
of T  cells bound to APCs has been previously described by 
Kupfer and Singer (38-40).  Thus we sought to determine 
whether  the  binding  of MHC  class  II +  B  cells  was  as- 
sociated with an altered distribution of CD4 within the cell 
membrane of CHO-CD4 cells. For these experiments, mono- 
layers of CHO-CD4 cells were incubated with Raft B cells 
for 4 h at 37~  to promote optimal adhesion.  Inasmuch as 
the maintenance  of stable CD4/MHC  class II adhesion is 
temperature dependent (6), the B cells were removed by in- 
cubation at 4~  The monolayers were then fixed, perme- 
abilized, immunostained with OKT4 mAbs, and visualized 
by indirect  immunofluorescence microscopy.  By contrast with 
the diffuse distribution of CD4 on control CHO-CD4 cells 
that  had not  encountered  MHC class  II §  B lymphocytes, O 
'~  4  v 
"o  f- 
--s 
o  QQ 
m  2 
G) 
O 
B 
￿9  ......  .  .  .~ 
0  1  2  3  4 
Time (hours) 
C 
o 
v 
"o  i- 
o  QQ 
0 
0 
i  i  i  i 
1  2  3  4 
Time (hours) 
0 
x 
"o 
c: 
:3 
o 
O 
k 
CHO-CD4  CHO-CD4-Y  CHO-CD4-F 
A  6 
D 
o 
"{3 
C 
0  m 
0 
0 
0 
i  i  i  i 
1  2  3  4 
Time (hours) 
Figure  6.  The protein tyrosine kinase activity of p56  t'~ regulates  CD4/MHC  class II adhesion.  (A) The binding of radiolabeled Raji B cells to 
monolayers  of CHO-CD4  (['-1), CHO-CD4-Y505  (O), CHO-CD4-F505  (A), CHO-CD4-Y505 KA27s (O), and CHO-CD4-FS05  ~273 (A) cells. (B) 
The binding of radiolabeled Raji B cells to monolayers  of CHO-CD4,  CHO-CD4-Y505,  or CHO-CD4-F505 cells in the absence (5 #1 DMSO, 1~), 
or presence of genistein (20 #g/ml, II; 100/lg/ml, m). Genistein was present throughout the entire four hour incubation. (C) The binding of radiola- 
beled Raji B cells to monolayers of CHO-CD4  ([]), CHO-CD4-Y505  (Q), CHO-CD4-YSO5VF394 (O) cells. (D) The binding of radiolabeled  Raft 
B cells to monolayers  of CHO-CD4  ([]),  CHO-CD4-FS05  (A) and CHO-CD4-FS05vF394  (A) cells. 
Figure  7.  Expresion of wild-type and mutant p56  t~k proteins in trans- 
fected CHO-CD4 cells. Equivalent amounts of total cell protein were pre- 
pared from ceil lysates of transfected cells as follows: (1) CHO-CD4-Y505, 
(2)  CHO-CD4-YS05 cAz0, (3)  CHO-CD4-Y505r  (4)  CHO-CD4- 
Y505 YF394, (5) CHO-CD4-FS05,  (6) CHO-CD4-FS05CA20,  (7) CHO- 
CD4-F505  ga~z73, (8) CHO-CD4-F505YF394 . Proteins were separated by 
SDS-PAGE, transferred to nitrocellulose and incubated with p56t~k-specific 
antiserum followed by 12SI-labeled  protein A-Sepharose. 
CD4 was found to be localized in patches at the cell surface 
after incubation with Raji B lymphocytes (Fig. 8). A corre- 
sponding redistribution of vinculin in CHO-CD4 cells was 
also detected after the binding of MHC class II-expressing 
B cells. Similar results were obtained with talin and oe-actinin 
(data not shown). The selective enrichment and redistribu- 
tion of cytoskeletal proteins with CD4 at junctional zones 
likely functions to stabilize CD4/MHC class II-mediated cell 
adhesion by increasing  the local density of CD4 capable of 
interacting with MHC class II molecules. 
p56  l~k Promotes  the Association  of CD4  with  the  Cytoskel- 
eton.  Interactions between cell surface molecules and the 
cytoskeleton can regulate the efficiency ofligand binding. For 
example, the binding of fibroblasts  to extracellular  matrix 
components is anchored by interactions between integrin mol- 
ecules and components of the actin cytoskeleton (41). A similar 
accumulation ofcadherins into adherens-typejunctions stabi- 
lizes cell-cell interactions (42). Consequently, pharmacolog- 
ical agents that disrupt the cytoskeleton, such as cytochalasins, 
also inhibit integrin- and cadherin-mediated adhesion events. 
1734  p56~  and CD4/MHC  Class II Adhesion Using  similar  strategies,  we  have  observed  that  stable 
CD4/MHC class II adhesion requires an intact cytoskeleton. 
Pharmacological  agents  such as cytochalasin D,  colchicine, 
and nocodazole, were shown to disrupt CHO-CD4-Raji B 
cell conjugates (6). To further examine how cytoskeletal in- 
teractions might  regulate CD4/MHC class II binding  and 
to determine the role of p56  zck in these interactions,  we as- 
sessed the physical association of CD4 with the cytoskeleton 
by measuring whether cell surface CD4 (_+  p56  ~k) was resis- 
tant  to solubilization with non-ionic detergent.  Using this 
technique, Geppert and Lipsky have previously demonstrated 
that a fraction ('-20%) of CD4 on peripheral blood T  cells 
is associated with the cytoskeleton (30). Cytoskeletal associ- 
ation can be evaluated experimentally by staining cell surface 
proteins with fluorescently labeled mAbs, treating  the cells 
with detergent to remove molecules not associated with the 
cytoskeleton, and assessing the remaining bound label by flow 
cytometry. For these experiments, CHO-CD4,  CHO-CD4- 
Y505, and CHO-CD4-FS05 cells were labeled with OKT4- 
FITC mAb, treated with 1.0% NP-40, and analyzed by flow 
cytometry (Fig. 9). Virtually all of the CD4 at the cell sur- 
face of CHO-CD4-YS05 cells was resistant to NP-40 treat- 
ment  thus  implying  a  strong  association  with  detergent- 
insoluble cytoskeletal components. By contrast, the majority 
of cell surface CD4 in CHO-CD4 and CHO-CD4-F505 cells 
was solubilized by detergent treatment and thus not associated 
with the cytoskeleton. These data indicate that the wild-type, 
but  not  the  mutant  (p5CkF505),  form of p56 ~k promotes 
interactions between CD4 and the cytoskeleton thereby sug- 
gesting a mechanism by which p56  ~k might regulate CD4/ 
MHC class II adhesion via the formation of CD4-associated 
adherens junctions. 
p56  ~k Regulates  the Formation  of CD4-associated  Adherens 
Junctions.  Previous studies have shown that the level of pro- 
tein tyrosine kinase activity regulates the formation and sta- 
bility of focal adhesions. For example, the formation of these 
structures can be blocked with specific tyrosine kinase inhib- 
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Figure  8.  CD4 aggregation  into adherens- 
type junctions. Monolayers  of CHO-CD4 
cells were incubated for 4 h in the presence 
(left) or absence (right) of Raji B cells. After 
the removal of bound MHC class II + B cells 
at 4~  the monolayers  were fixed, permea- 
bilized, and stained  for CD4 (OKT4 followed 
by rhodamine-conjugated goat anti-mouse 
IgG) (top) or vinculin (rabbit polyclonal  sera 
followed by  FITC-conjugated goat anti- 
rabbit IgG) (bottom). Staining was visualized 
by indirect immunofluorescence  microscopy 
(x630). 
itors (43).  Elevated protein tyrosine kinase activity can also 
dissociate integrin-mediatedjunctional  interactions (44, 45). 
Inasmuch as the level of tyrosine phosphorylation can differen- 
tially regulate the formation and stability of such cellular junc- 
tions,  we sought  to determine whether either form of the 
p56  ~k  tyrosine  kinase  influenced  the  formation  of CD4- 
associated adherens junctions.  After incubation  with  Raji, 
the fraction of CHO-CD4 cells displaying aggregated CD4 
was measured by indirect immunofluorescence staining with 
the OKT4  mAb.  Adherens junction  formation  is reported 
as the fraction of CHO-CD4 cells  that  display aggregated 
OKT4  staining  (Fig.  10).  In both  CHO-CD4  and CHO- 
CD4-Y505 cells, the formation of adherens junctions preceded 
detectable binding (compare with Fig. 2 B). Moreover, CD4 
adherens junctions were detected more rapidly in CHO-CD4- 
Y505 cells than in CHO-CD4 cells; consistent with the en- 
hanced time course and magnitude of Raji adhesion to CHO- 
CD4-Y505 cells. Further,  a greater fraction of CHO-CD4- 
Y505 cells displayed aggregated CD4 as compared with con- 
trol CHO-CD4 cells after 4 h of incubation with Raji B cells 
(Fig.  10). Adherens junction formation was also analyzed on 
CHO-CD4 clones expressing the KA273 mutants of p56  ~k 
(CHO-CD4-Y505 K^273 and  CHO-CD4-F505 Kn273  cells). 
Both the time course and magnitude  of CD4  aggregation 
were decreased with  CHO-CD4-Y505 Kn273 cells and more 
closely resembled the pattern of adherens junction formation 
seen in CHO-CD4 cells lacking p56  tck (Fig.  10).  Thus,  the 
protein tyrosine kinase activity of wild-type p56  ~k likely in- 
creases CD4/MHC class II adhesion by augmenting the for- 
mation of CD4-associated adherens junctions.  We propose 
that  p56  ~  mediates  an  increased  association  of CD4  with 
the cytoskeleton thereby facilitating  the formation of adherens 
junctions,  resulting  in  enhanced  cell-cell  adhesion. 
Strikingly,  CD4  aggregation  could  not  be detected  on 
CHO-CD4-F505 cells at any time after the introduction of 
MHC class  II + B  cells  (Fig.  10).  However, CD4  aggrega- 
tion  was  detectable  on  CHO-CD4  clones  expressing  the A  CHO-CD4  CHO-CD4-Y505  CHO-CD4-F505 
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Figure  9.  The association of CD4 with the cytoskeleton is enhanced by the presence of p56  t'k. The association of CD4 with the cytoskeleton was 
assessed by immunostaining  of CHO-CD4 cells (_+p56  ~k) with FITC-conjugated  OKT4 mAbs followed by treatment with 1.0% NP-40. (A) FACS  | 
profiles of CHO-CD4, CHO-CD4-YS05,  and CHO-CD4-FS05 cells before (top) or after (bottom)  treatment with detergent.  Staining with negative 
control P3X63 mAb is shown in open profiles, OKT4 staining in filled profiles. (B) The fraction of control (CHO-DUXK II, CD4-negative), CHO- 
CD4 (no pS6~k), CHO-CD4-YS05  (clone 5), and CHO-CD4-F505 (clone 2) cells expressing detergent-resistant CD4 molecules was assessed by flow 
cytometry.  The results presented are representative of three different experiments. 
kinase-deficient p56t~kF505  ~273 double mutant (Fig.  10,  A); 
suggesting that the enzymatic activity of the F505 mutant 
p56 ~  prevents CD4 aggregation. Moreover, the inability of 
CD4 to aggregate on CHO-CD4-FS05 cells correlates with 
the decreased binding  of MHC  class  II + Raji  B  cells.  In 
summary, these data strongly argue that elevated tyrosine phos- 
phorylation by p56 kk decreases CD4/MHC class II adhesion 
by inhibiting the formation of CD4-associated adherens  junc- 
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Figure  10.  The enzymatic activity of p56  ~  regulates the formation of 
CD4-associated adherens  junctions. The fraction of CHO-CD4 (Fq), CHO- 
CD4-YS05 (O), CHO-CD4-Y505 K^273 (O), CHO-CD4-F505 (A), and 
CHO-CD4-F505I~m273 (A) cells expressing aggregated CD4 after incu- 
bation with Raji B lymphocytes (4 h, 37~  Adherens junction forma- 
tion was assessed by indirect immunofluorescence staining with FITC- 
conjugated OKT4 mAb. At least 100 CHO cells representing at least 10 
different fields of view were counted for each sample and the data is repre- 
sentative of at least three  separate experiments. 
tions that are required for stable cell-cell adhesion mediated 
by CD4  and MHC class II molecules. 
Discussion 
The data presented in this report demonstrate that the ex- 
pression of a wild-type or constitutively activated form of 
the p56 ~k protein in CHO-CD4 cells differentially regulates 
the adhesion of MHC class II + B cells. Both the magnitude 
and the time course of CD4/MHC class II adhesion are en- 
hanced by the presence of wild-type p56 ~k as compared to 
cells expressing mutant/ck proteins.  The Ick protein likely 
influences CD4/MHC class II adhesion by effecting a redis- 
tribution of CD4, and other cytoskeletal proteins, at the cell 
surface into adherens-typejunctions at the site of interaction 
with an MHC class II-expressing cell. 
How might wild-type p56 ~k augment CD4/class II ad- 
hesion and the formation of adherens junctions?  p56 ~k is 
found associated with the detergent-insoluble fraction in both 
T  cells and transfected fibroblasts  (8,  46),  suggesting that 
p56 ~k may interact directly with cytoskeletal elements. Simi- 
larly,  we  observed  that  the  presence of wild-type p56 ~k 
renders CD4 resistant to detergent solubilization. We pro- 
pose that Ick interacts with components of the actin cyto- 
skeleton thus facilitating contacts with CD4 and providing 
a scaffold onto which adherens junctions can efficiently as- 
semble. Potential targets for this interaction include vinculin, 
talin, ot-actinin, and paxillin. Indirect immunofluorescence 
studies reveal that these proteins do, in fact, colocalize with 
CD4 within adherensjunctions (our manuscript in prepara- 
tion). While this scaffolding function may provide a mecha- 
nism to enhance CD4 adherens junction formation, the na- 
ture of the physical linkage is not known at present. One 
1736  p56  tck and CD4/MHC Class II Adhesion possibility is that the amino terminus of p56 ~k interacts with 
CD4 while simultaneously binding one or more cytoskeletal 
components through its SH2 or SH3 domains (47, 48). Al- 
ternatively, p56 ~k may phosphorylate specific cytosolic pro- 
teins which indirectly facilitate interactions between CD4 and 
the cytoskeleton. A  newly discovered family of tyrosine- 
phosphorylated proteins including cortactin and p130, as well 
as tyrosine kinases such as p125FAK (focal adhesion kinase), 
may also be involved (49). 
The interaction of a T  helper cell with an antigen pre- 
senting cell results from a number of adhesive interactions 
including those of LFA-1 with its ICAM ligands, CD2 and 
LFA-3,  and CD4 with MHC class II molecules. Whereas 
LFA-1/ICAM interactions are responsible for initial adhe- 
sion events, CD4-class II adhesive interactions are only de- 
tected after 2 h  (this report and references 6  and 50),  im- 
plying that CD4/class II binding is probably not involved 
in the initial formation of T  ceI1/APC conjugates. The in- 
ability to detect CD4/MHC class II adhesion at these earlier 
times likely reflects  the time required for the mobilization 
of CD4 into adherens-type junctions. The selective enrich- 
ment of CD4 at junctional zones likely stabilizes  cell adhe- 
sion by increasing the overall avidity of its interaction with 
MHC class II molecules and may be important for the long- 
term maintenance of stable T cell adhesion. This is supported 
by our observation that cell adhesion mediated by CD4 and 
class II is a stable, long-lived interaction that may be essential 
to the function of the T  helper cell, i.e., lymphokine secre- 
tion, and is in contrast with the rapid and transient interac- 
tion of cytolytic T  cells with their targets (51). 
The T cell receptor, LFA-1 and components of the microtu- 
bule organizing center colocalize with CD4 in the cell mem- 
brane of T  helper cells, oriented towards the site of interac- 
tion with an MHC class II + B lymphocyte (38--40, 51). The 
reorganization of cellular components correlates with antigen- 
specific recognition and is not detected in T cells bound to 
B cells expressing irrelevant antigen (39). LFA-/ICAM binding 
was  recognized  as  the  predominant  adhesive  interaction 
stabilizing T/B conjugates, and it was proposed that a redis- 
tribution of LFA-1 might facilitate TCR capping at the cell/cell 
junction (52).  As CD4 did not aggregate in the absence of 
LFA-l-mediated adhesion, it was presumed that the trans- 
cellular bond between CD4 and MHC class II was too weak 
to cause CD4 aggregation. Rather, interactions between TCR 
and CD4 were thought to selectively enhance CD4 accumu- 
lation at the T  cell/APC junction;  thereby increasing the 
avidity of the weak binding of CD4 to MHC class II. Thus, 
CD4 could only interact with MHC class II ligands once 
sequestered within the cell contact region. Recent observa- 
tions by our laboratory do not concur with this view of CD4 
function. Substantial CD4 adhesion and redistribution within 
the membrane can be detected in the absence of TCR or LFA-1 
molecules using this adhesion assay (this report and reference 
6). Moreover, there is increasing evidence that the CD4-MHC 
class II interaction is of sufficient avidity to contribute to T 
cell adhesion inasmuch as conjugates with B lymphocytes 
can be disrupted by CD4-specific mAbs (50, 53; and our un- 
published observations). Our data support a model in which 
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the molecular interaction of CD4 with MHC class II pro- 
teins facilitates cell adhesion by inducing the reorganization 
of CD4 (and perhaps the TCR and cytosolic components) 
at sites of cell/cell contact. 
How might this active reorganization of CD4 and cyto- 
skeletal proteins into adherens type  junctions influence T cell 
function in vivo? CD4  adherens junctions might stabilize 
cellular interactions at times when other adhesive interactions 
are no longer operative. This notion is supported by recent 
studies documenting the transient nature of LFA-l-mediated 
adhesions (54) and cascades ofT cell adhesions (55). The for- 
mation of CD4 adherens junctions might also define the area 
of surface contact between a T lymphocyte and specific APC. 
Using alloantigen immobilized onto variably sized latex beads, 
Mescher determined that a minimum cell diameter of 4-5 
#m is necessary for the productive recognition of presented 
antigen (56). The diameter of a CD4-associated adherens type 
junction encompasses a diameter of at least 6 #m on CHO- 
CD4 cells (our unpublished data),  suggesting that the cell 
contact region defined by this structure is within the range 
defined for productive T cell interactions. The aggregation 
of CD4 might directly influence T  cell signal transduction 
by aggregating p56 ~k molecules at the intercellular junction. 
Clustering of p56 ~k is known to induce its enzymatic activi- 
ties (8), potentially via autophosphorylation and the assembly 
of CD4 adherens junctions might provide a mechanism for 
the induction of tyrosine phosphorylation. Finally, biophys- 
ical measurements of receptor/ligand interactions reveal that 
ligand binding can facilitate cell signaling by increasing the 
duration of receptor aggregation (57).  Consequently, CD4 
adherensjunctions might enhance T cell signaling by increasing 
the length of time in which CD4 and TCR bind their common 
ligand,  the MHC class II molecule. 
Straus and Weiss have previously demonstrated that p56 ~ 
is essential for T  cell activation and IL-2 production using 
the JCAM-1 cell line which lacks the tck protein (58). Simi- 
larly, we demonstrate that mutants of the kk protein lacking 
kinase activity fail to support enhanced CD4/class II-medi- 
ated cell adhesion. These data appear to conflict with several 
recent reports which argue that the kinase function of p56/ck 
is not essential for its ability to enhance the responsiveness 
of a class II-reactive hybridoma (36,  59).  However, in both 
studies, kinase-deficient Ick proteins were expressed in parent 
cells which contained wild-type protein.  Moreover, those 
studies were designed to measure T  cell responsiveness and 
the kinase activity of the kk protein may be dispensable for 
the enhanced responsiveness  of a T cell hybridoma. By con- 
trast, we are solely measuring CD4-class II adhesion and our 
data demonstrate that the kinase activity of p56  ~  is essen- 
tial for enhanced cell adhesion. Inasmuch as the importance 
of CD4-class II adhesion has remained somewhat controver- 
sial, a direct demonstration of the regulation of CD4-mediated 
cell adhesion by an associated protein tyrosine kinase pro- 
vides new insight  into  the function(s) of both  CD4  and 
p56 ~k. Moreover, these results have general implications for 
the regulation of cell adhesion by tyrosine kinases and sug- 
gest that specific elements of the cytoskeleton may act as sub- 
strates  for this family of protein tyrosine kinases. Finally, the experiments presented in this report demon- 
strate that the constitutively elevated tyrosine kinase activity 
by p56  ~k  decreases  the  efficiency  of CD4/MHC  class  II 
adhesion and prevents the clustering of CD4 at sites of  cell-cell 
interaction. Enhanced levels of tyrosine phosphorylation of 
cellular substrates are observed in the presence of the F505 
form of the kinase although we have not as yet identified 
these proteins.  Elevated tyrosine kinase activity has previously 
been found to disrupt the aggregation of various integrin 
and cadherin adhesion molecules; thereby decreasing ceil/sub- 
stratum and cell/cell binding (44, 45). If a similar redistribu- 
tion of the cytoskeleton is necessary for the maintenance of 
stable T cell/APC conjugates, elevated kinase activity could 
transduce a signal for de-adhesion. This is currently under 
investigation in our laboratory. 
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